JP2014028813A5 - - Google Patents

Download PDF

Info

Publication number
JP2014028813A5
JP2014028813A5 JP2013169253A JP2013169253A JP2014028813A5 JP 2014028813 A5 JP2014028813 A5 JP 2014028813A5 JP 2013169253 A JP2013169253 A JP 2013169253A JP 2013169253 A JP2013169253 A JP 2013169253A JP 2014028813 A5 JP2014028813 A5 JP 2014028813A5
Authority
JP
Japan
Prior art keywords
gln
seq
ala
val
trp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013169253A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014028813A (ja
JP5722966B2 (ja
Filing date
Publication date
Priority claimed from EP06090166A external-priority patent/EP1897885A1/en
Priority claimed from EP07090079A external-priority patent/EP1985624A3/en
Application filed filed Critical
Publication of JP2014028813A publication Critical patent/JP2014028813A/ja
Publication of JP2014028813A5 publication Critical patent/JP2014028813A5/ja
Application granted granted Critical
Publication of JP5722966B2 publication Critical patent/JP5722966B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013169253A 2006-09-08 2013-08-16 18f標識物質のための化合物と方法 Active JP5722966B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP06090166A EP1897885A1 (en) 2006-09-08 2006-09-08 Compounds and methods for F labelled agents
EP06090166.7 2006-09-08
EP07090079A EP1985624A3 (en) 2007-04-23 2007-04-23 Single step method of radiofluorination of biologically active compounds or biomolecules
EP07090079.0 2007-04-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2009527069A Division JP5603074B2 (ja) 2006-09-08 2007-09-07 18f標識物質のための化合物と方法

Publications (3)

Publication Number Publication Date
JP2014028813A JP2014028813A (ja) 2014-02-13
JP2014028813A5 true JP2014028813A5 (enExample) 2014-09-25
JP5722966B2 JP5722966B2 (ja) 2015-05-27

Family

ID=39031005

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009527069A Active JP5603074B2 (ja) 2006-09-08 2007-09-07 18f標識物質のための化合物と方法
JP2013169253A Active JP5722966B2 (ja) 2006-09-08 2013-08-16 18f標識物質のための化合物と方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2009527069A Active JP5603074B2 (ja) 2006-09-08 2007-09-07 18f標識物質のための化合物と方法

Country Status (20)

Country Link
US (1) US8557776B2 (enExample)
EP (5) EP2279759A3 (enExample)
JP (2) JP5603074B2 (enExample)
KR (1) KR20090058553A (enExample)
AR (1) AR062726A1 (enExample)
AU (1) AU2007294124A1 (enExample)
BR (1) BRPI0716554A2 (enExample)
CA (2) CA2858907A1 (enExample)
CL (1) CL2007002620A1 (enExample)
CO (1) CO6150196A2 (enExample)
CR (1) CR10654A (enExample)
IL (4) IL197363A0 (enExample)
MA (1) MA30780B1 (enExample)
MX (1) MX2009002492A (enExample)
NO (1) NO20091428L (enExample)
PE (1) PE20080850A1 (enExample)
RU (1) RU2009112716A (enExample)
TN (1) TN2009000063A1 (enExample)
TW (1) TW200829277A (enExample)
WO (1) WO2008028688A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009002492A (es) 2006-09-08 2009-08-28 Bayer Schering Pharma Ag Agentes que comprenden compuestos marcados con 18f y metodos relacionados.
BRPI0721424A2 (pt) * 2007-03-01 2014-03-25 Bayer Schering Pharma Ag Métodos de radiofluoração
GB201013808D0 (en) 2010-08-18 2010-09-29 Ge Healthcare Ltd Peptide radiotracer compositions
WO2012094334A1 (en) * 2011-01-04 2012-07-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services One-step 18f labeling of biological substrates and uses of 18f labeled biological substrates
EP2717985A4 (en) * 2011-06-09 2015-02-25 Ge Healthcare Ltd DEVICE AND METHOD FOR DISTILLATION
CN108558939B (zh) * 2013-03-15 2021-08-24 癌靶技术有限责任公司 18f-标记的靶向psma的pet成像剂
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
GB201322456D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
WO2018152339A1 (en) * 2017-02-17 2018-08-23 Yale University Radiolabeled pharmaceuticals and methods of making and using same
TW202426655A (zh) 2017-07-11 2024-07-01 美商新索思股份有限公司 非天然核苷酸之導入及其方法
MA49767A (fr) 2017-08-03 2021-05-26 Synthorx Inc Conjugués de cytokine pour le traitement de maladies auto-immunes
US20210238124A1 (en) * 2018-04-20 2021-08-05 The General Hospital Corporation Acetylated prodrugs for delivery across the blood-brain barrier
CA3127689A1 (en) 2019-02-06 2020-08-13 Synthorx, Inc. Il-2 conjugates and methods of use thereof
CN113150065B (zh) * 2021-03-11 2022-07-08 武汉英纳氏药业有限公司 一种合成肽及其应用
US20240277876A1 (en) * 2021-05-20 2024-08-22 The Regents Of The University Of California Pet imaging tracers
EP4692065A1 (en) 2023-03-31 2026-02-11 Nissan Chemical Corporation Pyrazole compound and harmful organism control agent

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2795449B2 (ja) * 1987-09-24 1998-09-10 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 治療用ペプチド
US5723578A (en) * 1987-09-24 1998-03-03 The Administrators Of Tulane Educational Fund Peptide analogs of bombesin
US5084555A (en) 1989-08-21 1992-01-28 The Administrators Of The Tulane Educational Fund An octapeptide bombesin analog
WO1990003980A1 (en) * 1988-10-14 1990-04-19 Administrators Of The Tulane Educational Fund Therapeutic peptides
JP2846463B2 (ja) * 1989-06-02 1999-01-13 ジョージタウン・ユニバーシティー 抗ストレプトキナーゼ抗体の検出方法
US6232071B1 (en) 1990-06-11 2001-05-15 Gilead Sciences, Inc. Tenascin-C nucleic acid ligands
US5244883A (en) 1990-11-29 1993-09-14 The Administrators Of The Tulane Educational Fund Nonapeptide bombesin antagonists
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
US6436989B1 (en) 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
AP2000001856A0 (en) 1997-12-24 2000-09-30 Vertex Pharma Prodrugs of aspartyl protease inhibitors.
WO1999033795A1 (en) 1997-12-24 1999-07-08 Vertex Pharmaceuticals Incorporated Prodrugs of aspartyl protease inhibitors
AU2010299A (en) 1997-12-24 1999-07-19 Vertex Pharmaceuticals Incorporated Prodrugs os aspartyl protease inhibitors
US6639076B1 (en) * 1998-08-18 2003-10-28 Eli Lilly And Company Growth hormone secretagogues
ES2248084T3 (es) * 1999-06-14 2006-03-16 Eli Lilly And Company Inhibidores de serinproteasa.
US7115766B2 (en) * 2000-11-30 2006-10-03 Indiana University Research & Technology Corp. Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds
GB0115927D0 (en) 2001-06-29 2001-08-22 Nycomed Amersham Plc Solid-phase nucleophilic fluorination
GB0206750D0 (en) 2002-03-22 2002-05-01 Amersham Plc Radiofluorination methods
EP1497316B1 (en) 2002-04-09 2006-07-05 Eli Lilly And Company Growth hormone secretagogues
AU2003250899A1 (en) * 2002-08-09 2004-03-11 Astellas Pharma Europe B.V. Compounds binding to p-selectin
US20080063599A1 (en) 2002-11-18 2008-03-13 Jorge Setoain Quinquer Compounds Which Can Be Used To Diagnose And Monitor Diseases Associated With The Formation Of Amyloid Protein Fibrils
US7342095B2 (en) * 2003-02-20 2008-03-11 University Of South Florida Peptidomimetic inhibitors of STAT activity and uses thereof
GB0305704D0 (en) 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
WO2006083424A2 (en) 2004-12-28 2006-08-10 The Trustees Of Columbia University In The City Of New York Radiolabeled compounds and uses thereof
JP2009505962A (ja) 2005-07-29 2009-02-12 バイエル・ヘルスケア・エルエルシー 肥満を治療するためのビフェニルアミノ酸誘導体の製造および使用
US20080029548A1 (en) 2006-05-05 2008-02-07 Ann De Wree Fabric treatment dispensing package
MX2009002492A (es) 2006-09-08 2009-08-28 Bayer Schering Pharma Ag Agentes que comprenden compuestos marcados con 18f y metodos relacionados.

Similar Documents

Publication Publication Date Title
JP2014028813A5 (enExample)
JP2013173781A5 (enExample)
JP2012107057A5 (enExample)
JP2014102408A5 (enExample)
JP2011168603A5 (enExample)
JP2016512050A5 (enExample)
JP2011136981A5 (enExample)
JP2011182796A5 (enExample)
JP2013500200A5 (enExample)
JP2017005051A5 (enExample)
JP2013532130A5 (enExample)
JP2016104015A5 (enExample)
JP2010088434A5 (enExample)
JP2013181136A5 (ja) ポリイミド前駆体組成物、ポリイミド成形体、及び画像形成装置
JP2012094862A5 (enExample)
JP2011037885A5 (enExample)
JP2015003980A5 (enExample)
JP2016516394A5 (enExample)
JP2016200526A5 (enExample)
JP2018509309A5 (enExample)
JP2013531183A5 (enExample)
JP2017528146A5 (enExample)
JP2015174855A5 (enExample)
JP2017019744A5 (enExample)
JP2015030781A5 (enExample)